Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Filing lists "Zimmer Holdings, Inc." while metadata references "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K (Current Report)
Reporting Period: Quarter ended March 31, 2011
Report Date: April 28, 2011
This filing serves to report the results of operations for the first quarter of 2011. The detailed financial data is contained in the attached Press Release (Exhibit 99.1), which is incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1 (Press Release) and are not present in the body of this 8-K filing.
Non-GAAP Measures Discussed:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Net Earnings and Diluted EPS: Adjusted to exclude inventory step-up and special items (net of tax).
- Special Items Definition: Includes acquisition and integration costs, employee termination benefits, contract terminations, and asset impairment charges related to global restructuring.
Material Changes
The filing text does not provide specific quantitative comparisons to the prior period. It notes that the attached press release contains year-over-year percentage increases or decreases calculated on a constant currency basis and adjusted for special items to facilitate trend analysis.
Guidance, Outlook, and Management Commentary
Management Commentary: Management utilizes the disclosed non-GAAP measures internally to evaluate business performance. They assert these measures provide investors with a clearer view of ongoing operating results by masking distortions caused by restructuring and currency effects. Adjusted diluted EPS is also used as a metric for incentive compensation.
Guidance: The text mentions that the press release includes "projected adjusted diluted EPS," but the specific guidance figures are not included in this document.
Risks and Contingencies: The filing includes a standard disclaimer that the non-GAAP measures may not be comparable to those of other companies and should not be viewed as a substitute for GAAP measures. It also states that the information is furnished, not filed, and the registrant makes no admission as to the materiality of the information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net earnings, and EPS figures, as they are not in the 8-K body.
- Verify the reconciliation between the reported GAAP measures and the non-GAAP adjusted measures (specifically regarding inventory step-up and restructuring costs).
- Confirm the specific "projected adjusted diluted EPS" guidance mentioned in the text.
- Check the impact of foreign currency exchange rates on reported sales growth by comparing GAAP sales to constant currency sales.